Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme

This article was originally published here

These neutralizing effects were found to be comparable to or better than those seen with antibody candidates derived from patients who had recovered from COVID-19. The data were

The post Twist Bioscience announces potent SARS-CoV-2 neutralising data from Covid-19 therapeutic antibody programme appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply